Categories AlphaGraphs, Earnings, Health Care

AMGN Infographic: Amgen’s Q4 2022 profit drops on flat revenues

Amgen Inc. (NASDAQ: AMGN) said its revenues remained unchanged in the fourth quarter of 2022 when the biotechnology firm’s earnings declined.

Amgen Q4 2022 earnings infographic

Unadjusted earnings decreased to $4.09 per share in the December quarter from $4.40 per share in the year-ago period. The reported net income was $1.62 billion or $3.0 per share in the latest quarter, compared to $1.90 billion or $3.36 per share in the year-ago quarter.

Meanwhile, total revenues remained unchanged at $6.84 billion during the three-month period. A 4% increase in product sales was offset by weakness in the other business segments.

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

TC BioPharm develops safer, less expensive products to target more cancers: CEO Bryan Kobel

TC BioPharm (NASDAQ: TCBP) is a clinical-stage cell therapy company focused on the development of treatments for infectious diseases, including advanced allogeneic chimeric antigen receptor (CAR) T-cell therapy products for

Cintas Corp. (CTAS) Q3 2023 earnings and revenue increase

Uniform rental company Cintas Corporation (NASDAQ: CTAS) on Wednesday announced financial results for the third quarter of 2023, reporting higher earnings and revenues. At $2.19 billion, third-quarter revenues were up

Infographic: Micron (MU) reports net loss for Q2; revenue down 53%

Micron Technology Inc. (NASDAQ: MU) slipped to a loss in the second quarter of 2023 from a profit last year, hurt by a sharp fall in revenues. The chipmaker reported

Add Comment
Viewing Highlight